Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIANT Study
2009-017664-16Phase 4Active
- Sponsor
- Biotronik
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of clopidogrel in myocardial infarction (MI) (2 arms), sponsored by Biotronik. Primary endpoint: Composite of death, myocardial infarction, and stent thrombosis at 12 months. Started Dec 2009; status: active.
02
Drugs
clopidogrel
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2009-017664-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017664-16.